PARP14 can promote pancreatic cancer (PC) cell proliferation, anti-apoptosis, and GEM resistance, highlighting its potential role as a therapeutic target for PC (Yao et al., 2019). The gene discussed is PARP14; the disease is familial pancreatic carcinoma.